Tag
"Too often, chronic illness robs me of the joy I should be feeling while nurturing my hair. I want Wash Day to be an aspect of my life that I look forward to."
Nurse and patient advocate Catina Morrison shares tips for talking with your doctor about assessing goals and changing the course when needed.
The latest health headlines to help you stay informed, take control of your care, and advocate for better health.
The U.S. Food and Drug Administration (FDA) approved a new drug, anifrolumab (Saphnelo), for moderate to severe systemic lupus erythematosus (SLE). This is the first type 1 interferon receptor antagonist for lupus.
Gradually weaning off steroids may lead to less flares among lupus patients in remission than staying on a low-dose treatment, new research found.
In our Arthritis Awareness Month campaign that sought to raise awareness of the challenges of living with invisible illnesses, community members shared how they get others to understand a condition that can’t always be seen. Many said that they have given up on trying to explain their invisible illness to people who don’t want to understand.
A new study suggests that a one-unit increase in disease activity scores might increase risk of organ damage and early mortality for lupus patients.
Depression is common with lupus, but engaging in even just a little physical activity may significantly reduce your risk.
The medication helped improve kidney function in people with lupus nephritis significantly compared with those taking a placebo.
By Kelsey Kloss
A new study shows that lupus patients who need to take hydroxychloroquine can be reassured that it does not have a significant risk for serious heart toxicity.
By 
By 
By 
By 
By 
